L26/P-040 Redefining quality assurance for sperm DNA fragmentation testing: IQCs in an EQA-free landscape
Human Reproduction · 01.07.2026 · 41 (Supplement_1)
DOI: 10.1093/humrep/deag083.376 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von M.C. Aquilina und 5 weiteren Autor:innen.
Abstract (Originalsprache)
Study question How can robust internal quality controls (IQCs) be established for advanced semen testing when no external quality assessment (EQA) schemes exist? Summary answer Structured IQCs demonstrated that sperm DNA damage testing was highly repeatable and reproducible across operators, instruments, reagents, and sites, ensuring reliable advanced semen diagnostics What is known already Sperm DNA fragmentation is a clinically relevant biomarker associated with fertilisation potential, embryo development, and ART outcomes. While acridine orange–based flow cytometric tests (AOFT) are widely used for measuring sperm DNA damage, advanced semen tests lack formal EQA schemes. This makes rigorous IQC and full analytical validation essential to ensure inter-laboratory consistency and long-term assay reliability. Study design, size, duration A multi-phase validation study was conducted using frozen semen samples analysed repeatedly across different days, operators, flow cytometers, and reagent batches. Inter-laboratory and inter-operator reproducibility were assessed using semen sample aliquots tested across three sites and multiple operators. Participants/materials, setting, methods Semen samples were processed using an acid-induced acridine orange assay on a BD Accuri C6 Plus flow cytometer. Quality control included instrument performance checks, reagent validation, and positive/negative controls. Repeatability, reproducibility, and robustness were evaluated using coefficients of variation, Bland–Altman analysis, and linear regression. A subset of samples (n = 35) was additionally analysed using TUNEL for cross-assay comparison. Main results and the role of chance Repeatability was high, with CVs <10% across four samples analysed in 15 independent runs. No significant differences in % DNA Fragmentation Index were observed between different flow cytometers (n = 36; 23.2% ± 2.2% vs 22.9% ± 2.22%; p = 0.2975), between testing days (n = 73; 18.11% ± 1.46% vs 17.99% ± 1.48%; p = 0.4737), or between reagent batches for acridine orange (n = 21), acid detergent (n = 23), or TNE solutions (n = 22) (all p > 0.10). Inter-laboratory reproducibility was high with strong correlations between Site 1 and Site 2 (R²=0.9713) and between Site 1 and Site 3 (R²=0.961), as was inter-operator agreement (R²=0.9844–0.9859). Bland–Altman analysis comparing 123 samples with another commercial AOFT provider showed strong agreement and no proportional bias. AOFT and TUNEL results were significantly correlated (r = 0.692, p < 0.001). Limitations, reasons for caution The study used frozen rather than fresh samples, and further evaluation across a broader range of clinical scenarios may strengthen generalisability. Wider implications of the findings This is the first study to highlight strong quality control in the absence of EQA for sperm DNA fragmentation testing which could be applied to other such tests. The findings support the incorporation of structured internal and external quality control frameworks to maintain long-term assay reliability. Trial registration number No
Zitieren
APA
Aquilina, M., Rogers, S., Babu, D. K., Close, M., Ellis, P., & Homa, S. (2026). L26/P-040 Redefining quality assurance for sperm DNA fragmentation testing: IQCs in an EQA-free landscape. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.376
Vancouver
Aquilina M, Rogers S, Babu DK, Close M, Ellis P, Homa S. L26/P-040 Redefining quality assurance for sperm DNA fragmentation testing: IQCs in an EQA-free landscape. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.376
BibTeX
@article{Aquilina2026,
author = {Aquilina, M.C. and Rogers, S. and Babu, D.K. Kollu and Close, M. and Ellis, P. and Homa, S.},
title = {L26/P-040 Redefining quality assurance for sperm DNA fragmentation testing: IQCs in an EQA-free landscape},
journal = {Human Reproduction},
year = {2026},
volume = {41},
number = {Supplement_1},
doi = {10.1093/humrep/deag083.376}
}
EUVIMED